Skip to main content
OpenTrials

Clinical trial condition

HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer

Explore clinical trials studying HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer trial results

Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details
Completed

Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy

NCT02753686

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • Novartis Investigative Site Calgary, Alberta, Canada
  • Novartis Investigative Site Burnaby, British Columbia, Canada
  • Novartis Investigative Site North Vancouver, British Columbia, Canada
  • Novartis Investigative Site Richmond, British Columbia, Canada
View all 25 locations
View Trial Details

Related conditions